PubMed=22002975; DOI=10.1177/0300985811424734
York D., Higgins R.J., LeCouteur R.A., Wolfe A.N., Grahn R.A., Olby N.J., Campbell M., Dickinson P.J.
TP53 mutations in canine brain tumors.
Vet. Pathol. 49:796-801(2012)

PubMed=27251041; DOI=10.1093/jnen/nlw042; PMCID=PMC4913437
Dickinson P.J., York D., Higgins R.J., LeCouteur R.A., Joshi N., Bannasch D.L.
Chromosomal aberrations in canine gliomas define candidate genes and common pathways in dogs and humans.
J. Neuropathol. Exp. Neurol. 75:700-710(2016)

PubMed=28480569; DOI=10.1111/vco.12317; PMCID=PMC5677578
York D., Sproul C.D., Chikere N.L., Dickinson P.J., Angelastro J.M.
Expression and targeting of transcription factor ATF5 in dog gliomas.
Vet. Comp. Oncol. 16:102-107(2018)

PubMed=37254642; DOI=10.1111/vco.12912; PMCID=PMC10524959
Schrock M.S., Zalenski A.A., Tallman M.M., Kollin L., Bratasz A., Weeks G., Miller M.A., Sweeney C.N., Pluhar G.E., Olin M.R., Kisseberth W.C., Bentley R.T., Dickinson P.J., York D., Webb A., Wang X., Moore S., Venere M., Summers M.K.
Establishment and characterization of two novel patient-derived lines from canine high-grade glioma.
Vet. Comp. Oncol. 21:492-502(2023)

PubMed=37365849; DOI=10.1002/vms3.1181; PMCID=PMC10357258
Fuchs D., Rohrer Bley C., Morandi L., Tonon C., Weyland M.S., Nytko-Karouzakis K.J.
Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro.
Vet. Med. Sci. 9:1573-1583(2023)